Rechercher dans ce blog

Thursday, June 4, 2020

Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" - thelancet.com

[unable to retrieve full-text content]

  1. Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"  thelancet.com
  2. COVID-19: WHO Decides To Resume Clinical Trials For Anti-malaria Drug Hydroxychloroquine  India Today
  3. Researchers retract study that found big risks in using hydroxychloroquine to treat covid-19  The Washington Post
  4. Lancet retracts major Covid-19 paper that raised safety concerns about malaria drugs  CNBC
  5. Study on Safety of Malaria Drugs for Coronavirus Retracted  The New York Times
  6. View Full Coverage on Google News


Health - Latest - Google News
June 05, 2020 at 02:10AM
https://ift.tt/304aaq6

Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" - thelancet.com
Health - Latest - Google News
https://ift.tt/2zrj9Ud

No comments:

Post a Comment

Featured Post

Measles is “growing global threat,” CDC tells doctors in alert message - Ars Technica

Enlarge / A baby with measles. CDC The Centers for Disease Control and Prevention is putting clinicians on alert about the growing r...

Popular Posts